Minerva Neurosciences Inc

Insider buying shows optimism for Minerva Neurosciences: executives buy options before Phase 3 trial, signaling confidence in future data and potential upside.

Minerva Neurosciences insider buying signals confidence ahead of Phase‑3 roluperidone data, but investors must watch clinical milestones closely.